Numerous scientists have reported an overexpression of SET and CIP2A proteins in various types of human cancers, and the knockdown of SET or CIP2A proteins in cancer cells after transfection with SET- or CIP2A-targeted siRNA and shRNA resulted in a reduction of SET or CIP2A levels and inhibited tumor growth. This evidence concerns the gene SET and neoplasm.